Griffin Deep Genomics Platform

When a disease is developing in the body, the affected cells die and shed into the bloodstream. Life-threatening diseases like cancer leave a unique combination of mutations in the DNA of these dead cells. By investigating every single copy of cell-free DNA in a blood sample, we can gain a uniquely deep and comprehensive insight into the body’s current health status.

solution provider

0 shares

Griffin Deep Genomics Platform

By Quantgene

Benefits

AI & Machine Learning

Our clinical data pipeline continues to grow and provides us with valuable insights into early cancer detection patterns.

Quantgene’s technology uses a redesigned sequencing process.

The GRIFFIN CORE is a proprietary software infrastructure

Main Features

Combining Deep Genomic sequencing and AI to detect disease down to a single molecule.

Primary Audience

Clinicians, technologists, data scientists, and business innovators

Benefits

AI & Machine Learning

Our clinical data pipeline continues to grow and provides us with valuable insights into early cancer detection patterns.

Quantgene’s technology uses a redesigned sequencing process.

The GRIFFIN CORE is a proprietary software infrastructure

Main Features

Combining Deep Genomic sequencing and AI to detect disease down to a single molecule.

Primary Audience

Clinicians, technologists, data scientists, and business innovators

Learn More

The Cutting-Edge Of AI Cancer Detection
Detecting cancer might be AI’s most altruistic and convoluted challenge yet. Standard screening methods such as radiological imaging can miss signs of cancer, or return a false negative (as it does in 20-30% of cases).
READ MORE

Startup Pivoted to Offer COVID Testing
Jo Bhakdi, CEO and founder of Quantgene, explains why the next phase of “health security” is all about consumer-driven DNA sequencing.
READ MORE

Jo Bhakdi

Founder & Chief Executive Officer

Quantgene

We’re not a cancer company, we are a health protection and peace of mind company.